The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Uber Technologies, Inc. (UBER), ...

This was the stock's second consecutive day of losses.

Biotech giant Gilead Sciences, Inc. GILD is scheduled to report fourth-quarter and full-year 2024 results on Feb. 11, after ...

Georgia has big racial and gender discrepancies in PrEP uptake, said Patrick Sullivan, who is an epidemiology professor at Emory University and leads AIDSVu and PrEPVu, which track HIV data and access ...

We are facing a new threat to global health. The COVID-19 pandemic made it clear to health-care providers, public health practitioners, policy makers, and communities that pathogens do not respect ...

Salesforce on Wednesday announced it had appointed Robin Washington, who has served as one of its board directors since 2013, ...

Robin Washington joins Salesforce as COFO in March 2025 to lead its transformation in the new agentic era. Congratulations!

The long-running HIV market rivalry between Gilead Sciences and GSK is about to turn a new page this year as Gilead looks to ...

A combination of homegrown capabilities and significant acquisitions has made Cognizant a key player in bringing AI to ...

The deal was signed with the Energize programme, a renewable energy purchasing vehicle for pharmeceutical companies.

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...